NCT02479100View on ClinicalTrials.gov

Contrast Enhanced Spectral Mammography (CESM) Study

NAUnknownINTERVENTIONAL
Enrollment

103

Participants

Timeline

Start Date

March 22, 2016

Primary Completion Date

March 31, 2019

Study Completion Date

December 31, 2022

Conditions
Breast Cancer
Interventions
DIAGNOSTIC_TEST

Contrast Enhanced Spectral Mammogram

Undergo a Contrast Enhanced Spectral Mammogram in additional to standard of care

Trial Locations (1)

CB2 0QQ

Cambridge University Hospitals NHS Foundation Trust, Cambridge

Sponsors

Collaborators (1)

GE Healthcare
All Listed Sponsors
collaborator

University of Cambridge

OTHER

collaborator

GE Healthcare

INDUSTRY

lead

Cambridge University Hospitals NHS Foundation Trust

OTHER